Kerala Ayurveda reports revenue growth alongside widening annual losses
Standalone revenue climbed 17.6% to ₹85.48 crore, but the company finished the year with a consolidated net loss of ₹20.65 crore.
— 2 earlier stories on Kerala Ayurveda Ltd. →What's new
- Standalone revenue rose 17.6% to ₹85.48 crore for FY2025-26.
- Consolidated revenue reached ₹131.15 crore, a 9% increase.
- Auditors flagged significant trade receivables from subsidiaries without adequate provisioning.
Why this matters
Top-line growth is failing to translate into profitability, with losses deepening on both a standalone and consolidated basis. The auditor's emphasis of matter regarding unprovided receivables from subsidiaries raises questions about the quality of the company's balance sheet.
What we're watching
- Management's plan to address the unprovided subsidiary receivables.
- Any path to narrowing the consolidated net loss in the coming quarters.
- Cash flow generation relative to the reported revenue growth.
The full read
Kerala Ayurveda closed FY2025-26 with top-line growth that failed to stem widening losses. Standalone revenue reached ₹85.48 crore, marking a 17.6% increase, while consolidated revenue grew 9% to ₹131.15 crore.
Despite these gains, the company posted a consolidated net loss of ₹20.65 crore.
The audit report adds a layer of caution, noting an emphasis of matter regarding significant trade receivables from subsidiaries that remain unprovided, which suggests potential balance-sheet pressure from internal group transactions. As a routine annual disclosure, the figures provide a backward-looking view of the company's fiscal health, yet the core issue remains the persistent disconnect between revenue expansion and the company's ability to reach profitability.
Questions answered
- How did Kerala Ayurveda's revenue perform in FY2025-26?
- Standalone revenue grew by 17.6% to reach ₹85.48 crore, while consolidated revenue rose by 9% to ₹131.15 crore.
- What was the bottom-line result for the year?
- The company reported a standalone net loss of ₹14.74 crore and a consolidated net loss of ₹20.65 crore.
- What specific concern did the auditors raise?
- The audit report includes an emphasis of matter regarding significant trade receivables owed by subsidiaries for which no provision has been made.
- Is this filing a surprise to the market?
- No. The results are routine annual disclosures that align with market expectations for the period.
Story so far
All notes on KERALAYUR →- 25 May 2026 · 8:02 PM IST Kerala Ayurveda reports revenue growth alongside widening annual losses
- today Kerala Ayurveda reports wider losses despite double-digit revenue growth
- today Kerala Ayurveda reports revenue growth but losses widen for FY26